P3 Health Targeting Profitability In 2025, With Initial Revenue Guidance For The Year Of $1.350B-$1.5B And Adjusted EBITDA Of ($35)M-$5M.

Company provides preliminary 2025 guidance and advance notification of a proposed financing transaction to provide a $30 million unsecured promissory note

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered, physician-led population health management company, is targeting profitability in 2025, with initial revenue guidance for the year of $1.350 billion to $1.500 billion and Adjusted EBITDA of negative ($35) million to $5 million.